Providing a steady flow of breaking news, analysis, news briefs, document texts and more, all designed to ensure you have the best, most complete information available anywhere about what’s happening in drug pricing.

GlaxoSmithKline is suing Pfizer and BioNTech over alleged infringement of multiple GSK-owned patents in the creation of mRNA vaccines for COVID-19, the latest in a series of legal disputes between vaccine makers on the rights to the technology at the core of vaccines developed rapidly during the pandemic, often through collaboration between industry and the federal government.

Inside Drug Pricing Home Page


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.